Update on "open study of the catechol-O-methyltransferase inhibitor tolcapone in major depressive disorder"

Adenosine A2A receptor blockade promotes oligodendrocyte differentiation and myelination: Highlighting the potency of an edaravone-conjugated A2A receptor antagonist.

Neuropharmacology·2025

Zooplankton as a Bioindicator of Marine Contamination for Filter-Feeding Basking Sharks, Fin Whales and Devil Rays at Caprera Canyon (Mediterranean Sea).

Archives of environmental contamination and toxicology·2025

Integrating traditional and innovative monitoring approaches to monitor the marine biodiversity in the Tyrrhenian Sea (Mediterranean sea).

Marine environmental research·2025

Efficacy of fosfomycin-containing regimens in treating severe infections caused by KPC-producing klebsiella pneumoniae and carbapenem-resistant acinetobacter baumannii in critically ill patients.

International journal of antimicrobial agents·2024

Evaluation of the Adriatic Sea pollution using mesozooplankton as an environmental indicator.

Chemosphere·2024

REGOMA-OSS: a large, Italian, multicenter, prospective, observational study evaluating the efficacy and safety of regorafenib in patients with recurrent glioblastoma.

ESMO open·2024

Single-Dose Ayahuasca for Depressive and Anxiety Symptoms Associated With Cancer Diagnosis: A Single-Blind Feasibility Proof-of-Concept Trial.

Journal of clinical psychopharmacology·2026

Low-Dose Clozapine Versus Aripiprazole in Borderline Personality Disorder: A Prospective Naturalistic Study.

Journal of clinical psychopharmacology·2026

Efficacy and Tolerability of Zonisamide for Alcohol Use Disorder: A Systematic Review and Meta-Analysis.

Journal of clinical psychopharmacology·2026

The Antidepressant Effects of the mGlu2/3 Receptor Antagonist TS-161 in Treatment-Resistant Depression: A Phase IIa Proof-of-Concept Clinical Trial.

Journal of clinical psychopharmacology·2026

The Randomization Effect in a Double-Blind Placebo-Controlled Depression Study.

Journal of clinical psychopharmacology·2026

Memantine Augmentation for Obsessive-Compulsive Symptoms in Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.

Journal of clinical psychopharmacology·2026

Plant-derived Bioactive Compounds in Schizophrenia: Pharmacological Mechanisms and Emerging Drug Targets.

Current drug targets·2026

Synergistic Phytochemicals From Mitracarpus frigidus (Willd. ex Roem. & Schult.) K. Schum. and Lantana camara Linn. in Chitosan Biofilms: Antioxidant and Anti-Inflammatory Activities With Wound-Healing Potential.

Chemistry & biodiversity·2026

Whole-genome sequencing-based profiling of CYP2D6 structural variants in Japanese patients with solid tumors.

The Journal of toxicological sciences·2026

Phytochemical Analysis of Moroccan Mercurialis annua L. and Its Nephroprotective Activity: Evidence Supporting Traditional Renal Uses.

Chemistry & biodiversity·2026

Beyond HEMA: Shifts in the (Meth)acrylate Composition of Matched Nail Cosmetics Between 2023 and 2026.

Contact dermatitis·2026

Gypensapogenin I ameliorates liver fibrosis by targeting MST1, restoring Hippo pathway homeostasis, and inhibiting HSCs activation.

Chinese journal of natural medicines·2026

Related Experiment Videos

Update on "open study of the catechol-O-methyltransferase inhibitor tolcapone in major depressive disorder"

Related Concept Videos

Adenosine A2A receptor blockade promotes oligodendrocyte differentiation and myelination: Highlighting the potency of an edaravone-conjugated A2A receptor antagonist.

Zooplankton as a Bioindicator of Marine Contamination for Filter-Feeding Basking Sharks, Fin Whales and Devil Rays at Caprera Canyon (Mediterranean Sea).

Integrating traditional and innovative monitoring approaches to monitor the marine biodiversity in the Tyrrhenian Sea (Mediterranean sea).

Efficacy of fosfomycin-containing regimens in treating severe infections caused by KPC-producing klebsiella pneumoniae and carbapenem-resistant acinetobacter baumannii in critically ill patients.

Evaluation of the Adriatic Sea pollution using mesozooplankton as an environmental indicator.

REGOMA-OSS: a large, Italian, multicenter, prospective, observational study evaluating the efficacy and safety of regorafenib in patients with recurrent glioblastoma.

Single-Dose Ayahuasca for Depressive and Anxiety Symptoms Associated With Cancer Diagnosis: A Single-Blind Feasibility Proof-of-Concept Trial.

Low-Dose Clozapine Versus Aripiprazole in Borderline Personality Disorder: A Prospective Naturalistic Study.

Efficacy and Tolerability of Zonisamide for Alcohol Use Disorder: A Systematic Review and Meta-Analysis.

The Antidepressant Effects of the mGlu2/3 Receptor Antagonist TS-161 in Treatment-Resistant Depression: A Phase IIa Proof-of-Concept Clinical Trial.

The Randomization Effect in a Double-Blind Placebo-Controlled Depression Study.

Memantine Augmentation for Obsessive-Compulsive Symptoms in Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.

Plant-derived Bioactive Compounds in Schizophrenia: Pharmacological Mechanisms and Emerging Drug Targets.

Synergistic Phytochemicals From Mitracarpus frigidus (Willd. ex Roem. & Schult.) K. Schum. and Lantana camara Linn. in Chitosan Biofilms: Antioxidant and Anti-Inflammatory Activities With Wound-Healing Potential.

Whole-genome sequencing-based profiling of CYP2D6 structural variants in Japanese patients with solid tumors.

Phytochemical Analysis of Moroccan Mercurialis annua L. and Its Nephroprotective Activity: Evidence Supporting Traditional Renal Uses.

Beyond HEMA: Shifts in the (Meth)acrylate Composition of Matched Nail Cosmetics Between 2023 and 2026.

Gypensapogenin I ameliorates liver fibrosis by targeting MST1, restoring Hippo pathway homeostasis, and inhibiting HSCs activation.

Related Experiment Videos

Update on "open study of the catechol-O-methyltransferase inhibitor tolcapone in major depressive disorder"

Related Concept Videos

Related Articles